Terms: = Colorectal cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Treatment
606 results:
1. Morphological Changes Induced by TKS4 Deficiency Can Be Reversed by EZH2 Inhibition in colorectal Carcinoma Cells.
Jacksi M; Schad E; Tantos A
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672463
[TBL] [Abstract] [Full Text] [Related]
2. Role of imbalanced gut microbiota in promoting CRC metastasis: from theory to clinical application.
Fan S; Zhou L; Zhang W; Wang D; Tang D
Cell Commun Signal; 2024 Apr; 22(1):232. PubMed ID: 38637851
[TBL] [Abstract] [Full Text] [Related]
3. PTPLAD1 Regulates PHB-Raf Interaction to Orchestrate Epithelial-Mesenchymal and Mitofusion-Fission Transitions in colorectal cancer.
Huang ZJ; Li YJ; Yang J; Huang L; Zhao Q; Lu YF; Hu Y; Zhang WX; Liang JZ; Pan J; Pan YL; He QY; Wang Y
Int J Biol Sci; 2024; 20(6):2202-2218. PubMed ID: 38617530
[TBL] [Abstract] [Full Text] [Related]
4. The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer.
Rong Z; Zheng K; Chen J; Jin X
J Cancer Res Clin Oncol; 2024 Mar; 150(3):154. PubMed ID: 38521878
[TBL] [Abstract] [Full Text] [Related]
5. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin.
Zhang C; Zeng M; Xu Y; Huang B; Shi P; Zhu X; Cao Y
Gene; 2024 Jul; 914():148406. PubMed ID: 38521111
[TBL] [Abstract] [Full Text] [Related]
6. microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in bladder cancer by binding to eIF5A2.
Yang J; Xiang H; Cheng M; Jiang X; Chen Y; Zheng L; Yan S; Zhang S; Zhang C; Chen W; Chen D
Neoplasma; 2024 Feb; 71(1):60-69. PubMed ID: 38506035
[TBL] [Abstract] [Full Text] [Related]
7. Canonical DDR activation by emt inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
[TBL] [Abstract] [Full Text] [Related]
8. Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways.
Liu YF; Feng ZQ; Chu TH; Yi B; Liu J; Yu H; Xue J; Wang YJ; Zhang CZ
Phytomedicine; 2024 Apr; 126():155462. PubMed ID: 38394734
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of a germline variant TNS1 c.2999-1G > C in a hereditary cancer syndrome family.
Di X; Wang D; Wu J; Zhu X; Wang Y; Yan J; Wen L; Jiang H; Wen D; Shu B; Zhang S
Gene; 2024 May; 908():148304. PubMed ID: 38387708
[TBL] [Abstract] [Full Text] [Related]
10. OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.
Tang Y; Liu Y; Wang X; Guo H; Chen L; Hu G; Cui Y; Liang S; Zuo J; Luo Z; Chen X; Wang X
BMC Cancer; 2024 Feb; 24(1):204. PubMed ID: 38350902
[TBL] [Abstract] [Full Text] [Related]
11. Small extracellular vesicles promote the formation of the pre-metastatic niche through multiple mechanisms in colorectal cancer.
Wu J; Wang X; Li Z; Yi X; Hu D; Wang Q; Zhong T
Cell Cycle; 2024 Jan; 23(2):131-149. PubMed ID: 38341861
[TBL] [Abstract] [Full Text] [Related]
12. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote colorectal cancer Liver Metastasis.
Liu X; Wang X; Yang Q; Luo L; Liu Z; Ren X; Lei K; Li S; Xie Z; Zheng G; Zhang Y; Hao Y; Zhou Q; Hou Y; Fang F; Song W; Cui J; Ma J; Xie W; Shen S; Tang C; Peng S; Yu J; Kuang M; Song X; Wang F; Xu L
Cancer Res; 2024 Apr; 84(8):1352-1371. PubMed ID: 38335276
[TBL] [Abstract] [Full Text] [Related]
13. Deciphering the oncogenic landscape: Unveiling the molecular machinery and clinical significance of LncRNA TMPO-AS1 in human cancers.
Saraswat SK; Mahmood BS; Ajila F; Kareem DS; Alwan M; Athab ZH; Shaier JB; Hosseinifard SR
Pathol Res Pract; 2024 Mar; 255():155190. PubMed ID: 38330619
[TBL] [Abstract] [Full Text] [Related]
14. Downregulation of Roundabout guidance receptor 2 suppresses hepatocellular carcinoma progression by interacting with Y-box binding protein 1.
Liu T; Zhai C; Tian B; Li C; Han S; Wang S; Xuan M; Liu D; Zhao Y; Zhao H; Yu W; Wang J
Sci Rep; 2024 Jan; 14(1):2588. PubMed ID: 38297025
[TBL] [Abstract] [Full Text] [Related]
15. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
Zhang S; Fan W; He D
J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
[TBL] [Abstract] [Full Text] [Related]
16. Effect of Cichoric Acid on colorectal cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
Ma S; Huang Z; Chen Q; Yin X
Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
[TBL] [Abstract] [Full Text] [Related]
17. Entero-toxigenic
Yang J; Wang X; Hu T; Huang H; Chen G; Jin B; Zeng G; Liu J
Cell Cycle; 2024 Jan; 23(1):70-82. PubMed ID: 38273425
[TBL] [Abstract] [Full Text] [Related]
18. H19: An Oncogenic Long Non-coding RNA in colorectal cancer.
Chowdhury PR; Salvamani S; Gunasekaran B; Peng HB; Ulaganathan V
Yale J Biol Med; 2023 Dec; 96(4):495-509. PubMed ID: 38161577
[TBL] [Abstract] [Full Text] [Related]
19. Unveiling the role of miR-137-3p/miR-296-5p/SERPINA3 signaling in colorectal cancer progression: integrative analysis of gene expression profiles and in vitro studies.
Liu H; Wu X; Wang D; Li Q; Zhang X; Xu L
BMC Med Genomics; 2023 Dec; 16(1):327. PubMed ID: 38087342
[TBL] [Abstract] [Full Text] [Related]
20. CYP1B1-AS1 Delays the Malignant Progression of colorectal cancer by Binding with NOP58.
Wu Z; Cheng F; Yuan L; Li X; Li Z; Huang Z; Mao S; Chen X; Wang J; Lai B; Shen W
Dig Dis Sci; 2024 Feb; 69(2):437-452. PubMed ID: 38087130
[TBL] [Abstract] [Full Text] [Related]
[Next]
